Word: momenta
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...brief past, the biotech industry each year grows closer to losing sway with the moneymen who fund its research. Even though biotech stocks have been moving up this year, among critical pre-ipo investors like venture-capital funds "there's a lot of fear," says Alan Crane, ceo of Momenta Pharmaceuticals, an early-stage drug-discovery firm. "There's a lot of concern about losing your money." Mullen's focus on diverse products, production synergies and profitability is already part of the culture at top industry players Amgen and Genentech. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan...
...brief past, the industry each year grows closer to losing sway with the moneymen who fund its research. Even though biotech stocks have been moving up this year, among critical pre-IPO investors like venture-capital funds "there's a lot of fear," says Alan Crane, CEO of Momenta Pharmaceuticals, an early-stage drug-discovery firm. "There's a lot of concern about losing your money...